BPMX Scores A Facelift, MDVN Says "I Do" To PFE, Europe Gets Its 1st HIV PrEP

Shares of BioPharmX Corp. (BPMX) climbed more than 15% on Monday, following positive findings from the company's phase 2a safety study of BPX-01 in facial Propionibacterium acnes.

from RTT - Biotech http://ift.tt/2bdmSdX
via IFTTT